CureVac Enterprise Value Over E B I T D A from 2010 to 2024
| CVAC Stock | USD 2.51 0.09 3.46% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (2.48) | Current Value (2.60) | Quarterly Volatility 54.89628728 |
Check CureVac NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CureVac main balance sheet or income statement drivers, such as Tax Provision of 70.3 K, Net Interest Income of 5.7 M or Interest Income of 13.6 M, as well as many exotic indicators such as Price To Sales Ratio of 17.32, Dividend Yield of 0.0 or PTB Ratio of 2.19. CureVac financial statements analysis is a perfect complement when working with CureVac NV Valuation or Volatility modules.
CureVac | Enterprise Value Over E B I T D A |
Latest CureVac NV's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of CureVac NV over the last few years. It is CureVac NV's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CureVac NV's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
CureVac Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (89.21) | |
| Coefficient Of Variation | (61.54) | |
| Mean Deviation | 47.68 | |
| Median | (127.52) | |
| Standard Deviation | 54.90 | |
| Sample Variance | 3,014 | |
| Range | 125 | |
| R-Value | 0.85 | |
| Mean Square Error | 874.53 | |
| R-Squared | 0.73 | |
| Significance | 0.000049 | |
| Slope | 10.49 | |
| Total Sum of Squares | 42,190 |
CureVac Enterprise Value Over E B I T D A History
About CureVac NV Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include CureVac NV income statement, its balance sheet, and the statement of cash flows. CureVac NV investors use historical funamental indicators, such as CureVac NV's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although CureVac NV investors may use each financial statement separately, they are all related. The changes in CureVac NV's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CureVac NV's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on CureVac NV Financial Statements. Understanding these patterns can help to make the right decision on long term investment in CureVac NV. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (2.48) | (2.60) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CureVac NV in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CureVac NV's short interest history, or implied volatility extrapolated from CureVac NV options trading.
Pair Trading with CureVac NV
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CureVac NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will appreciate offsetting losses from the drop in the long position's value.Moving against CureVac Stock
| 0.8 | XFOR | X4 Pharmaceuticals Earnings Call Next Week | PairCorr |
| 0.71 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.68 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.67 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.66 | ELYM | Eliem Therapeutics | PairCorr |
The ability to find closely correlated positions to CureVac NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CureVac NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CureVac NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CureVac NV to buy it.
The correlation of CureVac NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CureVac NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CureVac NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CureVac NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of CureVac NV Correlation against competitors. For information on how to trade CureVac Stock refer to our How to Trade CureVac Stock guide.Note that the CureVac NV information on this page should be used as a complementary analysis to other CureVac NV's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for CureVac Stock analysis
When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is CureVac NV's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CureVac NV. If investors know CureVac will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CureVac NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.57) | Revenue Per Share 0.201 | Quarterly Revenue Growth 0.47 | Return On Assets (0.18) | Return On Equity (0.49) |
The market value of CureVac NV is measured differently than its book value, which is the value of CureVac that is recorded on the company's balance sheet. Investors also form their own opinion of CureVac NV's value that differs from its market value or its book value, called intrinsic value, which is CureVac NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CureVac NV's market value can be influenced by many factors that don't directly affect CureVac NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CureVac NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if CureVac NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CureVac NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.